Alira Health announced today that it closed an equity financing that brought in gross proceeds of $40 million.
Framingham, Massachusetts-based Alira Health works with healthcare and life sciences organizations as an international patient-centric and technology-enabled advisory firm. The company offers development to medical care to complement clients’ expertise with a range of services including research and clinical development solutions, technology-powered consulting and real-world evidence.
The company said it intends to use the funds raised to invest in solutions that actively engage patients in the delivery of services for healthcare providers, payers and suppliers.
“Alira Health’s mission is to humanize healthcare. We are extremely pleased to have the support of our investors who share our vision of putting patients at the center of healthcare transformation and innovation,” Alira CEO and Co-Founder Gabriele Brambilla said in the release. “This investment positions us to lead the market for delivering services using data collected directly from patients on digital health platforms. Our clients will have a clear advantage in developing and commercializing products by using patient-provided data to inform every stage of their product life cycle continuum.”
Creadev, a key existing investor for Alira Health, backed by the Mulliez family of France, provided the funds in the financing round.
“We continue to be impressed with Alira Health’s strategy and growth,” Creadev Healthcare Managing Director Yohann Gbahoué said. “Alira Health’s vision of patient-centric health care innovation, coupled with their ability to deliver on this promise, is truly revolutionary. We commend Alira Health on its transformational acquisitions and look forward to supporting the firm’s organic and inorganic growth.”
